CD19 and neoplasm: These findings indicate that CD19/CD20 dual-targeted CAR-NK cells, generated through the electroporation of CAR-mRNA into UCB-NK cells, can specifically recognize tumor cells expressing CD19 and/or CD20 antigens, leading to effective lysis.